News
B, Hepatitis-C, auto immune and metabolic liver disease etc. need to undergo regular screening by imaging and tumor markers.
Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April ...
DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences ... owned in vivo gene editing program designed to cure chronic hepatitis B by eliminating cccDNA, the key source of replicating hepatitis ...
8d
News-Medical.Net on MSNNew quinoline-based antiviral shows strong promise against SARS-CoV-2Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).
Stock analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for Cocrystal Pharma in a research report issued to clients and investors on Tuesday, April 1st. Zacks Small ...
3d
Baby Center Worldwide on MSNWhat is an amniocentesis and why you might be offered oneWhat is an amniocentesis? Amniocentesis (sometimes called "amnio") is a test in which your doctor takes a small sample of ...
Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...
The path forward for a medical cannabis bill in the Nebraska Legislature appears more uncertain after a committee chair ...
In the world of chemistry, some reactions are too slow or too difficult and require the assistance of metals that act as ...
Urges Stockholders to Vote FOR All Four Dynavax Director Nominees on the GOLD Proxy Card Highlights Record Financial ...
Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Highlights Record Financial and Operational Results, Balanced Capital Allocation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results